SCA-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT trangenic mice

Neoplasia

Volumn 10, Issue 12, 2008, Pages 1433-1443

  Grange, Cristina ^a   Lanzardo, Stefania ^a   Cavallo, Federica ^a   Camussi, Giovanni ^a   Bussolati, Benedetta ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ATAXIN 1; BETA1 INTEGRIN; CD24 ANTIGEN; CYTOKERATIN; DOXORUBICIN; TUMOR MARKER;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CELL SELECTION; CLONOGENESIS; EPITHELIUM TUMOR; FEMALE; IN VIVO CULTURE; MAMMARY GLAND; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR CELL; TUMOR CELL CULTURE;

EID: 57349087670     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08902     Document Type: Article

References (41)

1. Reya T, Morrison SJ, Clarcke MF, and Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
2. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, and Wahl GM (2006). Cancer stem cells - perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res 66, 9339-9344.
3. Al-Hajj M and Clarke MF (2004). Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282.
4. Rafii S and Lyden D (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9, 702-712.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, and Dirks PB (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401.
6. Collins AT, Berry PA, Hyde C, Stower MJ, and Maitland NJ (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65, 10946-10951.
7. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, and Ailles LE (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104, 973-978.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, and De Maria R (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115.
9. O'Brien CA, Pollet A, Gallinger S, and Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
10. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, and Herlyn M (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65, 9328-9337.
11. Bapat SA, Mali AM, Koppikar CB, and Kurrey NK (2005). Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65, 3025-3029.
12. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, and Clarke MF (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988.
13. Jacques TS, Relvas JB, Nishimura S, Pytela R, Edwards GM, Streuli CH, and ffrench-Constant C (1998). Neural precursor cell chain migration and division are regulated through different beta1 integrins. Development 125, 3167-3177.
14. Dontu G and Wicha MS (2005). Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 10, 75-86.
15. Fillmore CM and Kuperwasser C (2008). Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10, R25.
16. Ponti D, Costa A, Zaffarono N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, and Daidone MG (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65, 5506-5511.
17. Bussolati B, Grange C, Sapino A, and Camussi G (2008). Endothelial cell differentiation of human breast tumor stem/progenitors cells. J Cell Mol Med (Epub ahead of print).
18. Liu JC, Deng T, Lehal RS, Kim J, and Zacksenhaus E (2007). Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 67, 8671-8681.
19. Li Y and Rosen JM (2005). Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10, 17-24.
20. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, et al. (2003). Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100, 15853-15858.
21. Huang S, Chen Y, Podsypanina K, and Li Y (2008). Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice. Neoplasia 10, 118-124.
22. Stingl J and Caldas C (2007). Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7, 791-799.
23. Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, Melani C, Giovarelli M, Rossi I, Nanni P, De Giovanni C, et al. (1998). Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 188, 589-596.
24. Di Carlo E, Diodoro MG, Boggio K, Modesti A, Modesti M, Nanni P, Forni G, and Musiani P (1999). Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest 79, 1261-1269.
25. Korkaya H, Paulson A, Iovino F, and Wicha MS (2008). HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene (Epub ahead of print).
26. Phillips TM, Kim K, Vlashi E, McBride WH, and Pajonk F (2007). Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia 9, 1122-1129.
27. Astolfi A, Landuzzi L, Nicoletti G, De Giovanni C, Croci S, Palladini A, Ferrini S, Iezzi M, Musiani P, Cavallo F, et al. (2005). Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am J Pathol 166, 1205-1216.
28. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, and Clarke MF (2008). Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26, 364-371.
29. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, and Visvader JE (2006). Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88.
30. Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, and Deng CX (2008). Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci 4, 133-142.
31. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, and Goodell MA (2002). Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245, 42-56.
32. Lawson DA, Xin L, Lukacs RU, Cheng D, and Witte ON (2007). Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 104, 181-186.
33. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, and Nephew KP (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68, 4311-4320.
34. Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E, Sciacca FL, Ottolina A, Parati EA, La Porta C, et al. (2006). Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54, 850-860.
35. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL, and Yu JS (2007). Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25, 1645-1653.
36. Dean M, Fojo T, and Bates S (2005). Tumour stem cells and drug resistance. Nat Rev Cancer 5, 275-284.
37. Sakariassen PØ, Immervoll H, and Chekenya M (2007). Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 9, 882-892.
38. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, and Eaves CJ (2006). Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997.
39. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, et al. (2008). Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68, 4674-4682.
40. Holmes C and Stanford WL (2007). Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25, 1339-1347.
41. Spadaro M, Lanzardo S, Curcio C, Forni G, and Cavallo F (2004). Immunological inhibition of carcinogenesis. Cancer Immunol Immunother 53, 204-216.